- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04063969
Analysis of the Radiation Safety Climate in the Hybrid Angiography Suite
Analysis of the Radiation Safety Climate in the Hybrid Angiography Suite and Its Effects on Radiation Safety Performance
This study aims to measure the radiation safety climate in the hybrid angiography suite using self-assessment and to investigate the relationship of radiation safety climate with their self-reported safety behaviors.
The hypothesis is that a radiation safety climate does exist and can be measured using self-assessment. Additionally, it is expected that the radiation safety climate positively influences radiation safety behaviors.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Antwerpen, Belgium, 2610
- GZA Campus Sint Augustinus
-
-
Oost Vlaanderen
-
Ghent, Oost Vlaanderen, Belgium, 9000
- Algemeen Ziekenhuis Maria Middelares
-
Ghent, Oost Vlaanderen, Belgium, 9000
- Ghent University Hospital
-
-
West Vlaanderen
-
Brugge, West Vlaanderen, Belgium, 8000
- Az Sint Jan Brugge
-
Ieper, West Vlaanderen, Belgium, 8900
- Jan Yperman Ziekenhuis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
- Endovascular team members: vascular surgeons, surgical trainees, operating nurses
- Patients undergoing elective endovascular repair of infrarenal abdominal aortic aneurysm
Description
Endovascular team member group
Inclusion Criteria:
- Vascular surgeon OR surgical trainee OR operating nurse
- Active at one of the participating hospitals
Exclusion Criteria:
- No exclusion criteria apply to this study.
Patient group Inclusion Criteria
- Patient undergoing elective endovascular repair of infrarenal abdominal aortic aneurysm
Exclusion criteria
- Emergency repair (ruptured aneurysm)
- Additional interventional procedures (iliac aneurysm, treatment of peripheral vessel disease)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Endovascular team members
All vascular surgeons, surgical trainees, nurses active in the hybrid angiography suite at one of the participating centers will be invited to participate in the study. All participating team members complete an online questionnaire containing an assessment of their perceived radiation safety climate (28 items, 5 dimensions), radiation safety behaviors(2 items, 2 dimensions), radiation safety knowledge (single item) and radiation safety motivation (single item). All data will be stored pseudonymized. |
The rating tool contains 28 statements which cover 5 dimensions (Leadership, communication, commitment, resources, risk awareness) of the radiation safety climate. Participants are asked to indicate on a scale of 1 (completely disagree) - 3 (neutral) - 5 (completely agree) whether they agree with each statement. A composite radiation safety climate score is calculated by adding ratings on all items. Minimum scale score 28 - Maximum scale score 140
Other Names:
The rating tool contains 2 statements which cover 2 dimensions of the radiation safety behavior.
Participants are asked to indicate on a scale of 1 (completely disagree) - 3 (neutral) - 5 (completely agree) whether they agree with each statement.
A composite radiation safety behavior score is calculated by adding ratings on both items Minimum scale score 2 - Maximum scale score 10
Other Names:
The rating tool contains 2 statements which cover the radiation safety knowledge and behavior. Participants are asked to indicate on a scale of 1 (completely disagree) - 3 (neutral) - 5 (completely agree) whether they agree with each statement. Minimum item score 1 - maximum item score 5
Other Names:
|
|
Vascular surgical patients
In each center, five patients undergoing primary elective endovascular repair for an infrarenal abdominal aortic aneurysm (EVAR) will be enrolled in the study. For each participating patient, a set of demographical (BMI, case difficulty, ASA-grade,etc.), procedure-related (procedure duration, contrast use, etc.) and radiation dose parameters (DAP, cumulative air kerma) will be collected and stored in a pseudonymized way. Participation in this study has no effect on the interventional procedure, or the chosen approach. |
Collection of patient-related data points Demographic information: ASA-classification, BMI Procedure related information: Procedural time, approach, contrast usage case difficulty Radiation safety parameters: Air Kerma, DAP, fluoroscopy time
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-assessed radiation safety climate
Time Frame: Baseline measurement on study inclusion (Day 1)
|
Radiation safety climate using radiation safety climate tool
|
Baseline measurement on study inclusion (Day 1)
|
|
Self-assessed radiation safety behavior
Time Frame: Baseline measurement on study inclusion (Day 1)
|
Radiation safety behavior using radiation safety behavior tool
|
Baseline measurement on study inclusion (Day 1)
|
|
Self-assessed radiation safety knowledge and motivation
Time Frame: Baseline measurement on study inclusion (Day 1)
|
Radiation safety knowledge and motivation using rating tool
|
Baseline measurement on study inclusion (Day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Procedural radiation doses - Dose area product
Time Frame: Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
|
Procedural dose area product (DAP)
|
Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
|
|
Procedural radiation doses - cumulative air kerma
Time Frame: Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
|
Procedural cumulative air kerma (CAK)
|
Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
|
|
Procedural radiation doses - fluoroscopy time
Time Frame: Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
|
Procedural fluoroscopy time
|
Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B670201837824
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
National and Kapodistrian University of AthensCompletedHealthy Adults | Healthy Volunteers OnlyGreece
Clinical Trials on Assessment of radiation safety climate
-
Vietlife Healthcare CorporationVietnam National Cancer HospitalUnknown
-
Yale UniversityCompletedSelf Efficacy | Cognitive ReappraisalUnited States
-
Peking Union Medical College HospitalCompleted
-
The University of Texas Medical Branch, GalvestonCompletedBrain Injuries, TraumaticUnited States
-
Johns Hopkins Bloomberg School of Public HealthUS Department of Housing and Urban Development; Green and Healthy Homes InitiativeCompletedAccident Injury | Home InjuryUnited States
-
Groupe Hospitalier de la Region de Mulhouse et...CompletedMajor Neurocognitive DisorderFrance
-
Kayseri UniversityCompletedHealth Education | Knowledge, Attitudes, Practice | Food Safety | Practice Randomized Controlled Trial | Solomon | Food HandlersTurkey (Türkiye)
-
Western University, CanadaJohns Hopkins University; University of British Columbia; Canadian Institutes... and other collaboratorsCompletedDomestic ViolenceCanada
-
University of Massachusetts, WorcesterNational Institute of Mental Health (NIMH)CompletedSuicideUnited States